News
HYPMY
4.350
NaN%
--
Scotiabank Reaffirms Their Buy Rating on Hypera S.A. (HYPE3)
TipRanks · 03/16 08:45
Hypera S.A. Reports Strong Earnings Amid Challenges
TipRanks · 10/31/2025 00:10
Weekly Report: what happened at HYPMY last week (0908-0912)?
Weekly Report · 09/15/2025 11:15
Weekly Report: what happened at HYPMY last week (0901-0905)?
Weekly Report · 09/08/2025 11:18
Weekly Report: what happened at HYPMY last week (0825-0829)?
Weekly Report · 09/01/2025 11:13
Weekly Report: what happened at HYPMY last week (0818-0822)?
Weekly Report · 08/25/2025 11:24
Weekly Report: what happened at HYPMY last week (0811-0815)?
Weekly Report · 08/18/2025 11:16
Weekly Report: what happened at HYPMY last week (0804-0808)?
Weekly Report · 08/11/2025 11:23
Hypera Pharma Reports Q2 2025 Financial Results
TipRanks · 08/08/2025 04:06
Weekly Report: what happened at HYPMY last week (0728-0801)?
Weekly Report · 08/04/2025 11:26
Weekly Report: what happened at HYPMY last week (0721-0725)?
Weekly Report · 07/28/2025 11:26
Weekly Report: what happened at HYPMY last week (0714-0718)?
Weekly Report · 07/21/2025 11:16
Scotiabank Initiates a Buy Rating on Hypera S.A. (HYPE3)
TipRanks · 07/17/2025 11:49
Weekly Report: what happened at HYPMY last week (0707-0711)?
Weekly Report · 07/14/2025 11:26
Weekly Report: what happened at HYPMY last week (0630-0704)?
Weekly Report · 07/07/2025 11:16
Weekly Report: what happened at HYPMY last week (0623-0627)?
Weekly Report · 06/30/2025 11:23
Weekly Report: what happened at HYPMY last week (0616-0620)?
Weekly Report · 06/23/2025 11:15
Weekly Report: what happened at HYPMY last week (0609-0613)?
Weekly Report · 06/16/2025 11:23
Weekly Report: what happened at HYPMY last week (0602-0606)?
Weekly Report · 06/09/2025 11:24
Weekly Report: what happened at HYPMY last week (0526-0530)?
Weekly Report · 06/02/2025 11:33
More
Webull provides a variety of real-time HYPMY stock news. You can receive the latest news about Hypera Sa through multiple platforms. This information may help you make smarter investment decisions.
About HYPMY
Hypera SA is a Brazil-based company engaged in the pharmaceuticals sector. The Company operates in several markets with a variety of pharmaceutical products. The Company's products include: Mantecorp Farmasa, which is an under the umbrella brand; Addera D3, Nesina, Dramin, Alivium, Predsim, Lisador, and Rinosoro, which focus on several medical specialties involving primary care which are present in main therapeutic classes; Mantecorp Skincare, which offer dermo cosmetics recommended by dermatologists and also operates in this segment with the brands Simple Organic, which offers organic, vegan, and cruelty-free products, and Bioage, which focuses on the professional aesthetic treatment market; and Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina, which are over-the-counter medications provided throughout Brazil.